In a filing, Johnson & Johnson revealed its VP Corporate Controller Decker Robert J unloaded Company’s shares for reported $1.16 million on Feb 25 ’25. In the deal valued at $165.88 per share,6,999 shares were sold. As a result of this transaction, Decker Robert J now holds 21,001 shares worth roughly $3.29 million.
Then, Decker Robert J bought 6,999 shares, generating $1,161,010 in total proceeds.
Before that, Schmid Timothy sold 403 shares. Johnson & Johnson shares valued at $62,928 were divested by the EVP, WW Chair, MedTech at a price of $156.15 per share. As a result of the transaction, Schmid Timothy now holds 15,098 shares, worth roughly $2.36 million.
Leerink Partners downgraded its Johnson & Johnson [JNJ] rating to a Market perform from a an Outperform in a research note published recently. Wolfe Research began covering JNJ with “an Outperform” recommendation on November 15, 2024. Daiwa Securities revised its rating on July 23, 2024. It rated JNJ as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of JNJ
On Tuesday, Johnson & Johnson [NYSE:JNJ] saw its stock jump 0.79% to $156.45. Over the last five days, the stock has gained 1.31%. Johnson & Johnson shares have risen nearly 8.18% since the year began. Nevertheless, the stocks have risen 6.85% over the past one year.
How much short interest is there in Johnson & Johnson?
A steep rise in short interest was recorded in Johnson & Johnson stocks on 2025-05-15, growing by 1.78 million shares to a total of 22.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 21.02 million shares. There was a rise of 7.82%, which implies that there is a positive sentiment for the stock.
